← Leaderboards
Marcelo Gabriel Kazanietz
University Of Pennsylvania
$22,841,058
Attributed
$23,825,546
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,825,546 · 14
By mechanism
R01$23,041,146 · 10
P01$541,260 · 2
R56$162,500 · 1
R03$80,640 · 1
Top collaborators
- David Feldser3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Steven Mark Albelda$22,046,338
- Andrew R Haas$3,721,334
- Daniel Sterman$5,215,085
- Paul G Corn$1,308,057
- Carl H. June$35,377,952
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingSignal TransductionPlayMouse ModelTumorigenesisProtein Kinase CNeoplasm MetastasisPathway InteractionsPhenotypeTumorMalignant NeoplasmsTumor ProgressionCellsResponseReceptorDisease ProgressionFamilyCell MotilityOverexpressionCancer EtiologyOncogenicNude MiceLaboratoriesEtiology
Grant awards (73)
Rac guanine nucleotide exchange factors in lung cancer$934,459
R01 · FY2025 · CA · contact PI
Protein kinase C and lung carcinogenesis$653,908
R01 · FY2025 · CA · contact PI
Protein kinase C signaling in prostate cancer health disparities$583,194
R01 · FY2025 · CA · contact PI
Protein kinase C and lung carcinogenesis$640,695
R01 · FY2024 · CA · contact PI
Protein kinase C signaling in prostate cancer health disparities$576,595
R01 · FY2024 · CA · contact PI
Rac guanine nucleotide exchange factors in lung cancer$459,139
R01 · FY2024 · CA · contact PI
Protein kinase C and lung carcinogenesis$674,373
R01 · FY2023 · CA · contact PI
Protein kinase C signaling in prostate cancer health disparities$488,027
R01 · FY2023 · CA · contact PI
Rac guanine nucleotide exchange factors in lung cancer$461,082
R01 · FY2023 · CA · contact PI
Rac guanine nucleotide exchange factors in lung cancer$470,493
R01 · FY2022 · CA · contact PI
Effectors of protein kinase C-mediated tumor progression$35,453
R01 · FY2022 · CA · contact PI
Protein kinase C and lung carcinogenesis$162,500
R56 · FY2021 · ES · contact PI
Effectors of protein kinase C-mediated tumor progression$389,662
R01 · FY2020 · CA · contact PI
Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment$282,503
P01 · FY2020 · CA · contact PI
Protein kinase C and lung carcinogenesis$545,121
R01 · FY2019 · ES · contact PI
Effectors of protein kinase C-mediated tumor progression$377,972
R01 · FY2019 · CA · contact PI
CXCL13: a mediator of prostate cancer progression$345,414
R01 · FY2019 · CA · contact PI
Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment$258,757
P01 · FY2019 · CA · contact PI
Protein kinase C and lung carcinogenesis$391,197
R01 · FY2018 · ES · contact PI
Effectors of protein kinase C-mediated tumor progression$389,662
R01 · FY2018 · CA · contact PI
CXCL13: a mediator of prostate cancer progression$356,098
R01 · FY2018 · CA · contact PI
Protein kinase C and lung carcinogenesis$153,924
R01 · FY2018 · ES · contact PI
Protein kinase C and lung carcinogenesis$391,197
R01 · FY2017 · ES · contact PI
Effectors of protein kinase C-mediated tumor progression$389,662
R01 · FY2017 · CA · contact PI
CXCL13: a mediator of prostate cancer progression$356,098
R01 · FY2017 · CA · contact PI
Protein kinase C and lung carcinogenesis$391,197
R01 · FY2016 · ES · contact PI
Effectors of protein kinase C-mediated tumor progression$389,662
R01 · FY2016 · CA · contact PI
CXCL13: a mediator of prostate cancer progression$356,098
R01 · FY2016 · CA · contact PI
Protein kinase C and lung carcinogenesis$391,197
R01 · FY2015 · ES · contact PI
CXCL13: a mediator of prostate cancer progression$356,098
R01 · FY2015 · CA · contact PI
Prostate carcinogenesis and PKC signaling$325,646
R01 · FY2015 · CA · contact PI
ErbB receptor signaling via small G-proteins in breast cancer$369,864
R01 · FY2014 · CA · contact PI
Prostate carcinogenesis and PKC signaling$315,877
R01 · FY2014 · CA · contact PI
ErbB receptor signaling via small G-proteins in breast cancer$351,640
R01 · FY2013 · CA · contact PI
Prostate carcinogenesis and PKC signaling$306,108
R01 · FY2013 · CA · contact PI
ErbB receptor signaling via small G-proteins in breast cancer$367,015
R01 · FY2012 · CA · contact PI
Prostate carcinogenesis and PKC signaling$327,773
R01 · FY2012 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$315,567
R01 · FY2012 · CA · contact PI
Prostate carcinogenesis and PKC signaling$338,520
R01 · FY2011 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$315,567
R01 · FY2011 · CA · contact PI
ErbB receptor signaling via small G-proteins in breast cancer$306,070
R01 · FY2011 · CA · contact PI
ErbB receptor signaling via small G-proteins in breast cancer$361,923
R01 · FY2010 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$325,327
R01 · FY2010 · CA · contact PI
Heregulin signaling via small GTPases in mitogenesis and tumorigenesis$324,034
R01 · FY2010 · CA · contact PI
Prostate carcinogenesis and PKC signaling$317,047
R01 · FY2010 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$325,327
R01 · FY2009 · CA · contact PI
Heregulin signaling via small GTPases in mitogenesis and tumorigenesis$315,632
R01 · FY2009 · CA · contact PI
Prostate carcinogenesis and PKC signaling$314,450
R01 · FY2009 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$58,207
R01 · FY2009 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$325,327
R01 · FY2008 · CA · contact PI
Prostate carcinogenesis and PKC signaling$284,363
R01 · FY2008 · CA · contact PI
Chimaerins-receptors for diacylgly and phorbal esters$56,511
R01 · FY2008 · CA · contact PI
Chimaerins: new receptors for diacylglycerol & phorbol esters$317,857
R01 · FY2007 · CA · contact PI
Prostate carcinogenesis and PKC signaling$284,363
R01 · FY2007 · CA · contact PI
Chimaerins:new receptors for DIACYGLY & phorbol esters$68,272
R01 · FY2007 · CA · contact PI
Chimaerins:new receptors for DIACYGLY & phorbol esters$327,350
R01 · FY2006 · CA · contact PI
Prostate carcinogenesis and PKC signaling$292,855
R01 · FY2006 · CA · contact PI
Chimaerins:new receptors for DIACYGLY & phorbol esters$66,106
R01 · FY2006 · CA · contact PI
Chimaerins:new receptors for DIACYGLY &phorbol esters$335,228
R01 · FY2005 · CA
Prostate carcinogenesis and PKC signaling$299,903
R01 · FY2005 · CA
Chimaerins:new receptors for DIACYGLY &phorbol esters$54,025
R01 · FY2005 · CA
Chimaerins:new receptors for DIACYGLY &phorbol esters$335,228
R01 · FY2004 · CA
Prostate carcinogenesis and PKC signaling$314,528
R01 · FY2004 · CA
Chimaerins:receptors for diacylglycerol &phorbol esters$335,228
R01 · FY2003 · CA
Prostate Carcinogensis and PKC Signaling$285,300
R01 · FY2003 · CA
Prostate Carcinogensis and PKC Signaling$285,300
R01 · FY2002 · CA
Regulation of protein kinase C and cell cycle by PAH o-quinones and ROS$0
P01 · FY2002 · CA
CHIMAERINS--RECEPTORS FOR DIACYLGLY AND PHORBOL ESTERS$289,501
R01 · FY2001 · CA
Prostate Carcinogensis and PKC Signaling$249,638
R01 · FY2001 · CA
REGULATION OF METASTASIS BY CHIMERINS$40,320
R03 · FY2001 · TW
CHIMAERINS--RECEPTORS FOR DIACYLGLY AND PHORBOL ESTERS$281,067
R01 · FY2000 · CA
REGULATION OF METASTASIS BY CHIMERINS$40,320
R03 · FY2000 · TW
CHIMAERINS--RECEPTORS FOR DIACYLGLY AND PHORBOL ESTERS$23,925
R01 · FY2000 · CA